Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 200.50 | 387.67 | 334.54 | 1.1655 | 1.5741 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 312.50 | 200.50 | 399.67 | 334.54 | 1.2054 | 1.7056 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 200.50 | 418.50 | 334.54 | 1.2596 | 1.8822 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 312.50 | 200.50 | 339.50 | 334.54 | 1.0178 | 1.0796 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 200.50 | 268.50 | 334.54 | 0.8084 | 0.5195 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 312.50 | 200.50 | 188.00 | 334.54 | 0.5656 | -0.0876 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 200.50 | 372.00 | 334.54 | 1.1329 | 1.5873 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 927.00 | 828.71 | 1.1226 | 1.2619 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 903.50 | 828.71 | 1.0929 | 1.1969 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 987.17 | 828.71 | 1.1944 | 1.4043 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 625.00 | 414.82 | 1023.17 | 828.71 | 1.2395 | 1.5036 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 938.17 | 828.71 | 1.1273 | 1.2447 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 625.00 | 414.82 | 782.00 | 828.71 | 0.9432 | 0.8841 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 671.50 | 828.71 | 0.8145 | 0.6351 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 424.17 | 828.71 | 0.5151 | 0.0260 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 609.50 | 828.71 | 0.7383 | 0.4751 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2066.50 | 1981.73 | 1.0428 | 1.0662 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1907.67 | 1981.73 | 0.9626 | 0.9377 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2279.17 | 1981.73 | 1.1504 | 1.2368 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2084.33 | 1981.73 | 1.0529 | 1.0841 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2067.83 | 1981.73 | 1.0440 | 1.0697 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 1913.67 | 1981.73 | 0.9651 | 0.9413 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1470.83 | 1981.73 | 0.7418 | 0.5750 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 923.50 | 1981.73 | 0.4663 | 0.0882 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1088.00 | 1981.73 | 0.5492 | 0.2390 |